Press Resease

Alopecia Market by disease (Androgenic Alopecia, Alopecia Areata, Cicatricial Alopecia, Traction Alopecia, Alopecia Totalis, Alopecia Universalis, and Others, by drug type (Corticosteroids, 5 Ar Inhibitors and Others), by gender (Male, Female); by route of administration (Topical, Injectable and Oral) and distribution channel (Retail Pharmacies, Hospital Pharmacies and Online Pharmacies)– Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Published Date: 23-Mar-2020 Category: Healthcare Report Format : PDF Pages: 130 Report Code: ZMR-5328 Status : Published

Global demand for Alopecia market was valued at approximately USD 2.40 billion in 2019, and is expected to generate revenue of around USD 4.45 billion by end of 2026, growing at a CAGR of around 9.2% between 2019 and 2026.

Description

The report covers forecast and analysis for the Alopecia market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Alopecia market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Alopecia market on a global level. In order to give the users of this report a comprehensive view on the Alopecia market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein disease, drug type, gender, route of administration, distribution channel, and regional segments are benchmarked based on their market size, growth rate and general attractiveness.

The word alopecia means hair loss. Alopecia isn't limited to the scalp; it's possible on the body anywhere. The hair cycle comprises of three phases: Anagen, which is called as growth phase. Second phase is catagen, also called as rest phase and the fading phase, which is called as telogen phase. Ninety percent of the hair is in the development period (anagen) and the remainder, which corresponds to ten percent in the resting and shedding phases. When the hair falls out, this is the telogen phase and the hair is going to regenerate, and it begins to develop again in the (development) anagen process. Alopecia can be subdivided into two broad categories: scarring and non-scarring. Non-scarring or androgenic alopecia is the most common form. Many men start losing hair in the 20s, while women start losing their hair in their 40s or 50s. As a person grows older they lose hair. The pattern is the disparity between masculine hair loss and female hair loss. Front and temporal zone are the area where men usually lose hair because this area is more sensitive to di-hydrogen testosterone. while women appear to lose hair from the scalp's central field. Female hair loss will also not result in complete baldness, while male hair loss can result in complete baldness. Males do not loose hair in the back of the scalp as this area is androgenic hormone resistant.

The study provides a decisive view on the Alopecia market by segmenting the market based on disease, drug type, gender, route of administration, distribution channel, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2020 to 2026. Based on disease, the market is segmented into androgenic alopecia, alopecia areata, cicatricial alopecia, traction alopecia and others. The study projects that the alopecia areata will dominate the Alopecia market owing to the upsurge in the number of patients suffering with the alopecia areata.

Based on drug type, the market is segmented into corticosteroids, 5 ar inhibitors, potassium channel openers and others. Corticosteroids segment is expected to dominate the market due to the more number of patients being treated by Corticosteroids in treatment of alopecia areata. Based on gender, the market is segmented into male and female .Based on distribution channel, the market is segmented into Retail Pharmacies, Hospital Pharmacies and Online Pharmacies. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Geographically speaking, North America dominated the alopecia market. Large alopecia patient pool, availability of developed infrastructure, growing awareness and presence of key players has led to increased demand for alopecia treatment.

Global Alopecia Market

The increase in lifestyle spending as well as growing people's awareness drives the growth of the market for alopecia treatment. In addition, the rise in the occurrence of chronic diseases, like acute stress disorder, polycystic ovary disease (PCOD), hyperthyroidism, hypothyroidism, cancer, lupus, and hypopituitarism is accelerating the growth of the demand for alopecia treatment. Increasing aging population and increasing people concerned with improving the hair is expected to boost the market for alopecia treatment. The increasing demand for surgical hair transplants and increased customer awareness of possible treatment, like prp treatment which in turn boosts the growth of the market for alopecia treatment. However, the high cost and adverse effects associated with treatment may hamper the growth of the market for alopecia tretment.

Key players within global Alopecia market include Cipla Inc., Dr. Reddy’s Laboratories, Johnson and Johnson AG, Ranbaxy Laboratories Ltd, Transitions Hair Pty Ltd., Sun Pharmaceutical Industries Ltd., Merck & Co., Inc., Transitions Hair Pty Ltd, Cirrus Hair Centers, Lexington International LLC, Vita-Cos-Med Klett-Loch GmbH, Follica, Inc., and Capillus. amongst others.

The report segments global Alopecia market as follows:

Global Alopecia Market: Disease Segment Analysis

  • Androgenic alopecia
  • Alopecia areata
  • Cicatricial alopecia
  • Traction alopecia
  • Alopecia Totalis
  • Alopecia Universalis
  • Others

Global Alopecia Market: Drug type Segment Analysis

  • Corticosteroids
  • 5 AR Inhibitors
  • Potassium Channel openers
  • Others

Global Alopecia Market: By Gender Segment Analysis

  • Male
  • Female

Global Alopecia Market: By Route of Administration Segment Analysis

  • Topical
  • Oral
  • Injectable

Global Alopecia Market: Distribution channel Segment Analysis

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Alopecia Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Alopecia Market, 2016 - 2026, (USD Billion)
    • 2.2. Alopecia Market: Snapshot
  • Chapter 3. Global Alopecia Market – Industry Analysis
    • 3.1. Alopecia Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Fluctuating lifestyles leading to increasing levels of stress among the working class
      • 3.2.2. Increased geriatric population
      • 3.2.3. High demand for surgical hair transplants
      • 3.2.4. Increased customer awareness of possible treatment like prp treatment
    • 3.3. Restraints
      • 3.3.1. High cost of treatment
      • 3.3.2. Adverse effect
    • 3.4. Opportunity
      • 3.4.1. Economic growth paired by continuously growing medical expenditure
    • 3.5. Porter’s Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by disease segment
      • 3.6.2. Market attractiveness analysis by drug segment
      • 3.6.3. Market attractiveness analysis by gender segment
      • 3.6.4. Market attractiveness analysis by route of administration segment
      • 3.6.5. Market attractiveness analysis by distribution channel segment
      • 3.6.6. Market attractiveness analysis by regional segment
  • Chapter 4. Global Alopecia Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Alopecia market: company market share analysis, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New disease type launches
      • 4.2.3. Agreements, partnerships, cullaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global Alopecia Market – Disease Type Segment Analysis
    • 5.1. Global Alopecia market overview: by disease type
      • 5.1.1. Global Alopecia market revenue share, by disease type, 2019 and 2026
    • 5.2. Alopecia Areata
      • 5.2.1. Global Alopecia market by Alopecia Areata, 2016-2026 (USD Billion)
    • 5.3. Androgenic Alopecia
      • 5.3.1. Global Alopecia market by Androgenic Alopecia, 2016-2026 (USD Billion)
    • 5.4. Cicatricial Alopecia
      • 5.4.1. Global Alopecia market by Cicatricial Alopecia, 2016-2026 (USD Billion)
    • 5.5. Traction Alopecia
      • 5.5.1. Global Alopecia market by Traction Alopecia, 2016-2026 (USD Billion)
    • 5.6. Alopecia Totalis
      • 5.6.1. Global Alopecia market by Alopecia Totalis, 2016-2026 (USD Billion)
    • 5.7. Alopecia Universalis
      • 5.7.1. Global Alopecia market by Alopecia Universalis, 2016-2026 (USD Billion)
    • 5.8. Others
      • 5.8.1. Global Alopecia market by Others, 2016-2026 (USD Billion)
  • Chapter 6. Global Alopecia Market – Drug type Segment Analysis
    • 6.1. Global Alopecia market overview: by drug type
      • 6.1.1. Global Alopecia market revenue share, by drug type, 2019 and 2026
    • 6.2. Growth Factors
      • 6.2.1. Global Alopecia market by Growth Factors, 2016-2026 (USD Billion)
    • 6.3. Corticosteroids
      • 6.3.1. Global Alopecia market by Corticosteroids, 2016-2026 (USD Billion)
    • 6.4. 5 AR Inhibitors
      • 6.4.1. Global Alopecia market by 5 AR Inhibitors, 2016-2026 (USD Billion)
    • 6.5. Potassium Channel openers
      • 6.5.1. Global Alopecia market by Potassium Channel openers, 2016-2026 (USD Billion)
    • 6.6. Others
      • 6.6.1. Global Alopecia market by Others, 2016-2026 (USD Billion)
  • Chapter 7. Global Alopecia Market – Gender Segment Analysis
    • 7.1. Global Alopecia market overview: by gender
      • 7.1.1. Global Alopecia market revenue share, by gender, 2019 and 2026
    • 7.2. Male
      • 7.2.1. Global Alopecia market by Male, 2016-2026 (USD Billion)
    • 7.3. Female
      • 7.3.1.Global Alopecia market by female, 2016-2026 (USD Billion)
  • Chapter 8. Global Alopecia Market – Route of Administration Segment Analysis
    • 8.1. Global Alopecia market overview: by route of administration
      • 8.1.1. Global Alopecia market revenue share, by route of administration, 2019 and 2026
    • 8.2. Topical
      • 8.2.1.Global Alopecia market by Topical, 2016-2026 (USD Billion)
    • 8.3. Oral
      • 8.3.1. Global Alopecia market by Oral, 2016-2026 (USD Billion)
    • 8.4. Injectable
      • 8.4.1. Global Alopecia market by Injectable, 2016-2026 (USD Billion)
  • Chapter 9. Global Alopecia Market – Distribution Channel Segment Analysis
    • 9.1. Global Alopecia market overview: by distribution channel
      • 9.1.1. Global Alopecia market revenue share, by distribution channel, 2019 and 2026
    • 9.2. Hospital Pharmacies
      • 9.2.1. Global Alopecia market by Hospital Pharmacies, 2016-2026 (USD Billion)
    • 9.3. Retail Pharmacies
      • 9.3.1. Global Alopecia market by Retail Pharmacies, 2016-2026 (USD Billion)
    • 9.4. Online Pharmacies
      • 9.4.1. Global Alopecia market by Online Pharmacies, 2016-2026 (USD Billion)
  • Chapter 10. Global Alopecia Market - Regional Analysis
    • 10.1. Global Alopecia market overview: by region
      • 10.1.1. Global Alopecia market revenue share, by region, 2019 and 2026
    • 10.2. North America
      • 10.2.1. North America Alopecia market, by country, 2016-2026 (USD Billion)
      • 10.2.2. North America Alopecia market revenue, by disease type, 2016-2026 (USD Billion)
      • 10.2.3. North America Alopecia market revenue, by drug type, 2016-2026 (USD Billion)
      • 10.2.4. North America Alopecia market revenue, by gender, 2016-2026 (USD Billion)
      • 10.2.5. North America Alopecia market revenue, by route of administration, 2016-2026 (USD Billion)
      • 10.2.6. North America Alopecia market revenue, by distribution channel, 2016-2026 (USD Billion)
      • 10.2.7. The U.S.
        • 10.2.7.1. The U.S. Alopecia market revenue, by disease type, 2016-2026 (USD Billion)
        • 10.2.7.2. The U.S. Alopecia market revenue, by drug type, 2016-2026 (USD Billion)
        • 10.2.7.3. The U.S. Alopecia market revenue, by gender, 2016-2026 (USD Billion)
        • 10.2.7.4. The U.S. Alopecia market revenue, by route of administration, 2016-2026 (USD Billion)
        • 10.2.7.5. The U.S. Alopecia market revenue, by distribution channel, 2016-2026 (USD Billion)
      • 10.2.8. Rest of North America
        • 10.2.8.1. Rest of North America Alopecia market revenue, by disease type, 2016-2026 (USD Billion)
        • 10.2.8.2. Rest of North America Alopecia market revenue, by drug type, 2016-2026 (USD Billion)
        • 10.2.8.3. Rest of North America Alopecia market revenue, by gender, 2016-2026 (USD Billion)
        • 10.2.8.4. Rest of North America Alopecia market revenue, by route of administration, 2016-2026 (USD Billion)
        • 10.2.8.5. Rest of North America Alopecia market revenue, by distribution channel, 2016-2026 (USD Billion)
    • 10.3. Europe
      • 10.3.1. Europe Alopecia market, by country, 2016-2026 (USD Billion)
      • 10.3.2. Europe Alopecia market revenue, by disease type, 2016-2026 (USD Billion)
      • 10.3.3. Europe Alopecia market revenue, by drug type, 2016-2026 (USD Billion)
      • 10.3.4. Europe Alopecia market revenue, by gender, 2016-2026 (USD Billion)
      • 10.3.5. Europe Alopecia market revenue, by route of administration, 2016-2026 (USD Billion)
      • 10.3.6. Europe Alopecia market revenue, by distribution channel, 2016-2026 (USD Billion)
      • 10.3.7. U.K.
        • 10.3.7.1. U.K. Alopecia market revenue, by disease type, 2016-2026 (USD Billion)
        • 10.3.7.2. U.K. Alopecia market revenue, by drug type, 2016-2026 (USD Billion)
        • 10.3.7.3. U.K. Alopecia market revenue, by gender, 2016-2026 (USD Billion)
        • 10.3.7.4. U.K. Alopecia market revenue, by route of administration, 2016-2026 (USD Billion)
        • 10.3.7.5. U.K. Alopecia market revenue, by distribution channel, 2016-2026 (USD Billion)
      • 10.3.8. France
        • 10.3.8.1. France Alopecia market revenue, by disease type, 2016-2026 (USD Billion)
        • 10.3.8.2. France Alopecia market revenue, by drug type, 2016-2026 (USD Billion)
        • 10.3.8.3. France Alopecia market revenue, by gender, 2016-2026 (USD Billion)
        • 10.3.8.4. France Alopecia market revenue, by route of administration, 2016-2026 (USD Billion)
        • 10.3.8.5. France Alopecia market revenue, by distribution channel, 2016-2026 (USD Billion)
      • 10.3.9. Germany
        • 10.3.9.1. Germany Alopecia market revenue, by disease type, 2016-2026 (USD Billion)
        • 10.3.9.2. Germany Alopecia market revenue, by drug type, 2016-2026 (USD Billion)
        • 10.3.9.3. Germany Alopecia market revenue, by gender, 2016-2026 (USD Billion)
        • 10.3.9.4. Germany Alopecia market revenue, by route of administration, 2016-2026 (USD Billion)
        • 10.3.9.5. Germany Alopecia market revenue, by distribution channel, 2016-2026 (USD Billion)
      • 10.3.10. Rest of Europe
        • 10.3.10.1. Rest of Europe Alopecia market revenue, by disease type, 2016-2026 (USD Billion)
        • 10.3.10.2. Rest of Europe Alopecia market revenue, by drug type, 2016-2026 (USD Billion)
        • 10.3.10.3. Rest of Europe Alopecia market revenue, by gender, 2016-2026 (USD Billion)
        • 10.3.10.4. Rest of Europe Alopecia market revenue, by route of administration, 2016-2026 (USD Billion)
        • 10.3.10.5. Rest of Europe Alopecia market revenue, by distribution channel, 2016-2026 (USD Billion)
    • 10.4. Asia Pacific
      • 10.4.1. Asia Pacific Alopecia market, by country, 2016-2026 (USD Billion)
      • 10.4.2. Asia Pacific Alopecia market revenue, by disease type, 2016-2026 (USD Billion)
      • 10.4.3. Asia Pacific Alopecia market revenue, by drug type, 2016-2026 (USD Billion)
      • 10.4.4. Asia Pacific Alopecia market revenue, by gender, 2016-2026 (USD Billion)
      • 10.4.5. Asia Pacific Alopecia market revenue, by route of administration, 2016-2026 (USD Billion)
      • 10.4.6. Asia Pacific Alopecia market revenue, by distribution channel, 2016-2026 (USD Billion)
      • 10.4.7. China
        • 10.4.7.1. China Alopecia market revenue, by disease type, 2016-2026 (USD Billion)
        • 10.4.7.2. China Alopecia market revenue, by drug type, 2016-2026 (USD Billion)
        • 10.4.7.3. China Alopecia market revenue, by gender, 2016-2026 (USD Billion)
        • 10.4.7.4. China Alopecia market revenue, by route of administration, 2016-2026 (USD Billion)
        • 10.4.7.5. China Alopecia market revenue, by distribution channel, 2016-2026 (USD Billion)
      • 10.4.8. Japan
        • 10.4.8.1. Japan Alopecia market revenue, by disease type, 2016-2026 (USD Billion)
        • 10.4.8.2. Japan Alopecia market revenue, by drug type, 2016-2026 (USD Billion)
        • 10.4.8.3. Japan Alopecia market revenue, by gender, 2016-2026 (USD Billion)
        • 10.4.8.4. Japan Alopecia market revenue, by route of administration, 2016-2026 (USD Billion)
        • 10.4.8.5. Japan Alopecia market revenue, by distribution channel, 2016-2026 (USD Billion)
      • 10.4.9. India
        • 10.4.9.1. India Alopecia market revenue, by disease type, 2016-2026 (USD Billion)
        • 10.4.9.2. India Alopecia market revenue, by drug type, 2016-2026 (USD Billion)
        • 10.4.9.3. India Alopecia market revenue, by gender, 2016-2026 (USD Billion)
        • 10.4.9.4. India Alopecia market revenue, by route of administration, 2016-2026 (USD Billion)
        • 10.4.9.5. India Alopecia market revenue, by distribution channel, 2016-2026 (USD Billion)
      • 10.4.10. Rest of Asia Pacific
        • 10.4.10.1. Rest of Asia Pacific Alopecia market revenue, by disease type, 2016-2026 (USD Billion)
        • 10.4.10.2. Rest of Asia Pacific Alopecia market revenue, by drug type, 2016-2026 (USD Billion)
        • 10.4.10.3. Rest of Asia Pacific Alopecia market revenue, by gender, 2016-2026 (USD Billion)
        • 10.4.10.4. Rest of Asia Pacific Alopecia market revenue, by route of administration, 2016-2026 (USD Billion)
        • 10.4.10.5. Rest of Asia Pacific Alopecia market revenue, by distribution channel, 2016-2026 (USD Billion)
    • 10.5. Latin America
      • 10.5.1. Latin America Alopecia market, by country, 2016-2026 (USD Billion)
      • 10.5.2. Latin America Alopecia market revenue, by disease type, 2016-2026 (USD Billion)
      • 10.5.3. Latin America Alopecia market revenue, by drug type, 2016-2026 (USD Billion)
      • 10.5.4. Latin America Alopecia market revenue, by gender, 2016-2026 (USD Billion)
      • 10.5.5. Latin America Alopecia market revenue, by route of administration, 2016-2026 (USD Billion)
      • 10.5.6. Latin America Alopecia market revenue, by distribution channel, 2016-2026 (USD Billion)
      • 10.5.7. Brazil
        • 10.5.7.1. Brazil Alopecia market revenue, by disease type, 2016-2026 (USD Billion)
        • 10.5.7.2. Brazil Alopecia market revenue, by drug type, 2016-2026 (USD Billion)
        • 10.5.7.3. Brazil Alopecia market revenue, by gender, 2016-2026 (USD Billion)
        • 10.5.7.4. Brazil Alopecia market revenue, by route of administration, 2016-2026 (USD Billion)
        • 10.5.7.5. Brazil Alopecia market revenue, by distribution channel, 2016-2026 (USD Billion)
      • 10.5.8. Rest of Latin America
        • 10.5.8.1. Rest of Latin America Alopecia market revenue, by disease type, 2016-2026 (USD Billion)
        • 10.5.8.2. Rest of Latin America Alopecia market revenue, by drug type, 2016-2026 (USD Billion)
        • 10.5.8.3. Rest of Latin America Alopecia market revenue, by gender, 2016-2026 (USD Billion)
        • 10.5.8.4. Rest of Latin America Alopecia market revenue, by route of administration, 2016-2026 (USD Billion)
        • 10.5.8.5. Rest of Latin America Alopecia market revenue, by distribution channel, 2016-2026 (USD Billion)
    • 10.6. Middle East & Africa
      • 10.6.1. Middle East & Africa Alopecia market, 2016-2026 (USD Billion)
      • 10.6.2. Middle East & Africa Alopecia market revenue, by disease type, 2016-2026 (USD Billion)
      • 10.6.3. Middle East & Africa Alopecia market revenue, by drug type, 2016-2026 (USD Billion)
      • 10.6.4. Middle East & Africa Alopecia market revenue, by gender, 2016-2026 (USD Billion)
      • 10.6.5. Middle East & Africa Alopecia market revenue, by route of administration, 2016-2026 (USD Billion)
      • 10.6.6. Middle East & Africa Alopecia market revenue, by distribution channel, 2016-2026 (USD Billion)
  • Chapter 11. Company Profiles
    • 11.1. Cipla Inc.
      • 11.1.1. Overview
      • 11.1.2. Financials
      • 11.1.3. Product Portfolio
      • 11.1.4. Business Strategy
      • 11.1.5. Recent Developments
    • 11.2. Dr. Reddy’s Laboratories
      • 11.2.1. Overview
      • 11.2.2. Financials
      • 11.2.3. Product Portfolio
      • 11.2.4. Business Strategy
      • 11.2.5. Recent Developments
    • 11.3. Johnson and Johnson AG
      • 11.3.1. Overview
      • 11.3.2. Financials
      • 11.3.3. Product Portfolio
      • 11.3.4. Business Strategy
      • 11.3.5. Recent Developments
    • 11.4. Ranbaxy Laboratories Ltd
      • 11.4.1. Overview
      • 11.4.2. Financials
      • 11.4.3. Product Portfolio
      • 11.4.4. Business Strategy
      • 11.4.5. Recent Developments
    • 11.5. Transitions Hair Pty Ltd
      • 11.5.1. Overview
      • 11.5.2. Financials
      • 11.5.3. Product Portfolio
      • 11.5.4. Business Strategy
      • 11.5.5. Recent Developments
    • 11.6. Sun Pharmaceutical Industries Ltd
      • 11.6.1. Overview
      • 11.6.2. Financials
      • 11.6.3. Product Portfolio
      • 11.6.4. Business Strategy
      • 11.6.5. Recent Developments
    • 11.7. Merck & Co., Inc
      • 11.7.1. Overview
      • 11.7.2. Financials
      • 11.7.3. Product Portfolio
      • 11.7.4. Business Strategy
      • 11.7.5. Recent Developments
    • 11.8. Transitions Hair Pty Ltd
      • 11.8.1. Overview
      • 11.8.2. Financials
      • 11.8.3. Product Portfolio
      • 11.8.4. Business Strategy
      • 11.8.5. Recent Developments
    • 11.9. Cirrus Hair Centers.
      • 11.9.1. Overview
      • 11.9.2. Financials
      • 11.9.3. Product Portfolio
      • 11.9.4. Business Strategy
      • 11.9.5. Recent Developments
    • 11.10. Lexington International LLC
      • 11.10.1. Overview
      • 11.10.2. Financials
      • 11.10.3. Product Portfolio
      • 11.10.4. Business Strategy
      • 11.10.5. Recent Developments

Methodology

}